Tag Archives: pancreatic cancer diagnose

Henrietta Lacks: At Your Cervix

This video should go ‘viral’. Every woman in the world should view this.

Vaccines are biological weapons.  Do not submit to be killed by them.  Stay the F$$$ out from them and if you are near them call Homeland Security and the EPA for a biohazard cleanup.

All other videos on the topic of Henrietta Lacks make it appear as if her cancerous cervical cells are the greatest thing for medicine and humanity in general, and while i understand, from a research perspective, how beneficial cells like this would be. i am curious how anyone “benefits” from receiving cancer cells that never die in vaccines. Since we have had vaccines, cancer deaths have skyrocketed, as well as autism, diabetes and a slue of other debilitating diseases.

Source:

vaccinefraud

 Patrick Jordan @ http://www.VaccineFraud.com

 

Fair Use Notice: Images/logos/graphics on this page contains some copyrighted material whose use has not been authorized by the copyright owners. We believe that this not-for-profit, educational, and/or criticism or commentary use on the Web constitutes a fair use of the copyrighted material (as provided for in section 107 of the US Copyright Law).

Drug Information Update- FDA approves new treatment for advanced pancreatic cancer

Drug Information Update- FDA approves new treatment for advanced pancreatic cancer
FDA Division of Drug Information: Know the Moment It Happens

The Division of Drug Information (DDI) is CDER’s focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA.

The U.S. Food and Drug Administration today approved Onivyde (irinotecan liposome injection), in combination with fluorouracil and leucovorin, to treat patients with advanced (metastatic) pancreatic cancer who have been previously treated with gemcitabine-based chemotherapy.

According to the National Cancer Institute, there will be 48,960 new cases of pancreatic cancer diagnosed in the U.S. in 2015, and nearly the same number of deaths caused by the disease (40,560). Pancreatic cancer can be difficult to diagnose early and treatment options are limited, especially when the disease has spread to other parts of the body (metastatic disease) and surgery to remove the tumor is not possible.

The safety of Onivyde was evaluated in 398 patients who received either Onivyde with fluorouracil/leucovorin, Onivyde alone or
fluorouracil/leucovorin. The most common side effects of treatment with Onivyde included diarrhea, fatigue, vomiting, nausea, decreased appetite, inflammation in the mouth (stomatitis) and fever (pyrexia). Onivyde was also found to result in low counts of infection-fighting cells (lymphopenia and neutropenia). Death due to sepsis following neutropenia has been reported in patients treated with Onivyde.

The labeling for Onivyde includes a boxed warning to alert health care professionals about the risks of severe neutropenia and diarrhea. Onivyde is not approved for use as a single agent for the treatment of patients with metastatic pancreatic cancer.

For more information, please visit: Onivyde
.